Dezhan Healthcare Company Limited (SHE:000813)
China · Delayed Price · Currency is CNY 4.070
-0.050 (-1.21%)
Feb 3, 2026, 3:04 PM CST
Dezhan Healthcare Company Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 388.61 | 465.59 | 496.37 | 570.74 | 729.81 | 961.47 |
Other Revenue | 0.9 | 0.9 | 1.72 | 0.11 | 4.67 | 1.39 |
| 389.51 | 466.49 | 498.09 | 570.86 | 734.48 | 962.87 | |
Revenue Growth (YoY) | -24.72% | -6.35% | -12.75% | -22.28% | -23.72% | -45.75% |
Cost of Revenue | 157.06 | 170.39 | 223.13 | 359.44 | 261.42 | 294.39 |
Gross Profit | 232.45 | 296.09 | 274.96 | 211.41 | 473.06 | 668.47 |
Selling, General & Admin | 301 | 293.26 | 263.26 | 303.62 | 342.89 | 359.22 |
Research & Development | 61.29 | 68.37 | 51.1 | 51.49 | 67.06 | 56.05 |
Other Operating Expenses | 13.06 | 10.54 | 11.47 | 9.46 | 12.3 | 17.36 |
Operating Expenses | 376.88 | 378.02 | 330.64 | 364.51 | 423.29 | 434.52 |
Operating Income | -144.43 | -81.92 | -55.69 | -153.1 | 49.77 | 233.95 |
Interest Expense | -1.77 | -0.37 | -0.37 | -0.71 | -0.65 | -0.19 |
Interest & Investment Income | 54.12 | 66.36 | 148.32 | 86.8 | 84.82 | 118.14 |
Currency Exchange Gain (Loss) | 0 | 0 | -1.87 | -3.46 | -0.23 | -0.3 |
Other Non Operating Income (Expenses) | -9.67 | -10.28 | -10.95 | -9.94 | -164.68 | -4.47 |
EBT Excluding Unusual Items | -101.75 | -26.21 | 79.45 | -80.4 | -30.97 | 347.15 |
Impairment of Goodwill | - | - | - | - | -14.2 | - |
Gain (Loss) on Sale of Investments | -23.69 | -19.87 | - | - | - | 0.92 |
Gain (Loss) on Sale of Assets | -0.16 | -0.02 | -0.03 | 0.33 | 0.02 | -0.15 |
Asset Writedown | -1.43 | -1.56 | -7.23 | -41.98 | -0.31 | -2.34 |
Other Unusual Items | 7.3 | 3.55 | 9.65 | 0.98 | 8.36 | 3.68 |
Pretax Income | -119.72 | -44.11 | 81.84 | -121.08 | -37.11 | 349.26 |
Income Tax Expense | 2.71 | -1.89 | 27.6 | 32.38 | 59.09 | 75.62 |
Earnings From Continuing Operations | -122.43 | -42.22 | 54.24 | -153.46 | -96.2 | 273.64 |
Minority Interest in Earnings | 32.9 | 21.81 | 29.07 | 106.51 | 38.62 | 10.9 |
Net Income | -89.53 | -20.41 | 83.31 | -46.95 | -57.58 | 284.54 |
Net Income to Common | -89.53 | -20.41 | 83.31 | -46.95 | -57.58 | 284.54 |
Net Income Growth | - | - | - | - | - | -15.55% |
Shares Outstanding (Basic) | 2,098 | 2,149 | 2,181 | 2,215 | 2,241 | 2,220 |
Shares Outstanding (Diluted) | 2,098 | 2,149 | 2,181 | 2,215 | 2,241 | 2,220 |
Shares Change (YoY) | -3.88% | -1.48% | -1.52% | -1.15% | 0.95% | 0.07% |
EPS (Basic) | -0.04 | -0.01 | 0.04 | -0.02 | -0.03 | 0.13 |
EPS (Diluted) | -0.04 | -0.01 | 0.04 | -0.02 | -0.03 | 0.13 |
EPS Growth | - | - | - | - | - | -15.60% |
Free Cash Flow | -189.27 | -181.14 | -31.86 | 94.16 | -84.51 | 717.25 |
Free Cash Flow Per Share | -0.09 | -0.08 | -0.01 | 0.04 | -0.04 | 0.32 |
Dividend Per Share | - | - | - | - | - | 0.210 |
Gross Margin | 59.68% | 63.47% | 55.20% | 37.04% | 64.41% | 69.42% |
Operating Margin | -37.08% | -17.56% | -11.18% | -26.82% | 6.78% | 24.30% |
Profit Margin | -22.98% | -4.38% | 16.73% | -8.22% | -7.84% | 29.55% |
Free Cash Flow Margin | -48.59% | -38.83% | -6.40% | 16.50% | -11.51% | 74.49% |
EBITDA | -64.41 | -1.32 | 25.7 | -64.27 | 127.85 | 302.53 |
EBITDA Margin | -16.54% | -0.28% | 5.16% | -11.26% | 17.41% | 31.42% |
D&A For EBITDA | 80.02 | 80.61 | 81.39 | 88.83 | 78.08 | 68.57 |
EBIT | -144.43 | -81.92 | -55.69 | -153.1 | 49.77 | 233.95 |
EBIT Margin | -37.08% | -17.56% | -11.18% | -26.82% | 6.78% | 24.30% |
Effective Tax Rate | - | - | 33.72% | - | - | 21.65% |
Revenue as Reported | 389.51 | 466.49 | 498.09 | 570.86 | 734.48 | 962.87 |
Advertising Expenses | - | 46.35 | 52.54 | 108.97 | 148.13 | 173.76 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.